Revolutionizing Gene Therapy with Igor Fisch CEO of NewBiologix

Send us Fan MailIn this episode of the Life Science Success Podcast, Don Davis PhD, MBA interviews Igor Fisch, founder of NewBiologix. Igor shares his journey from academia to entrepreneurship, highlighting his success with Selexis, a company he sold in 2017 that specialized in monoclonal antibodies. He discusses the challenges of gene therapy, specifically the high costs, and NewBiologix's innovative approach to making gene therapy more affordable. Igor also provides insights into the industry's future, emphasizing the significance of stable production platforms for viral particles. 00:00 Introduction and Welcome 00:15 Igor's Journey into Life Sciences 00:37 The Success of Selexis 00:56 Transition to Gene Therapy 03:32 Challenges in Gene Therapy 03:50 The Importance of Stable Platforms 05:11 The Role of Biotech Startups 05:57 Balancing Science and Business 06:51 Networking at BIO Conference 08:14 Future Vision for New Biologics 09:21 Conclusion and Farewell